Search Results
Active Filters
Making a selection with these dropdown will cause content on this page to change. News search result will update as each option is selected.
Aug 27, 2025, 15:07 ET Novavax's Nuvaxovid™ 2025-2026 Formula COVID-19 Vaccine Approved in the U.S.
safety of NVX-CoV2373 in adults in the United States and Mexico. New England Journal of Medicine. 2022;386(6):531-543. doi:10.1056/NEJMoa2116185.Áñez G. et al. Safety, Immunogenicity, and Efficacy of the NVX-CoV2373 COVID-19
More news about: Novavax, Inc.
May 19, 2025, 07:00 ET U.S. FDA Approves BLA for Novavax's COVID-19 Vaccine
https://vaers.hhs.gov. About Nuvaxovid™Nuvaxovid (NVX-CoV2705) is an updated version of Novavax's prototype COVID-19 vaccine (NVX-CoV2373) formulated to target the JN.1 variant. It is a protein-based vaccine made by creating copies of the surface
More news about: Novavax, Inc.